In the present study, we have investigated the FcγRIIIA158V>F and FcγRIIA131H>R genotype frequencies in patients with BC overexpressing HER-2 and their role in the extent of in vitro trastuzumab-dependent lysis of HER2-positive BC cells. Here, ERBB2 is linked to breast cancer.